Skip to main content
SpringerLink
Log in

CV events persist for one year after stopping Vioxx

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Baron JA, Sandler RS, Bresalier RS, Lanas A, Morton DG, Riddell R, Iverson ER, DeMets DL.Cardiovascular events associated with rofecoxib: final analysis of the APPROVe trial. Lancet 372: 1756-1764, No. 9651, 15 Nov 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

CV events persist for one year after stopping Vioxx. React. Wkly. 1225, 1 (2008). https://doi.org/10.2165/00128415-200812250-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200812250-00001

Keywords

Search

Navigation